Professor Jaanus Harro and his research team have recently published an important study in Acta Neuropsychiatrica showcasing the effects of METTL3/METTL14 activators on anxiety-related behaviours.
Chemestmed is attending BIOEurope! Join us in Stockholm, Sweden, from November 4–6, 2024, to celebrate the event's 30th anniversary. Meet our team Dr. Sigrid Selberg, Prof. Mati Karelson and Prof. Jaanus Harro.
Chemestmed was thrilled to participate in the BIO International Convention in San Diego from June 3-6.
Join us at BIO 2024, June 3-6 in San Diego! Chemestmed will be located in the Estonia Pavilion at booth #3541.
Dr. Sigrid Selberg joins Chemestmed as Chief Scientific Officer.
In a preprint deposited in Cold Spring Harbor Laboratory server bioRxiv, Chemestmed reports in collaboration with the Universities of Tartu and Helsinki remarkable neuroprotective effects of our unique RNA m6A methyltransferase METTL3/METTL14/WTAP activators in vitro and in vivo PD animal model.